紫杉醇联合顺铂治疗蒽环类耐药晚期乳腺癌的临床观察_临床医学论文 关键词】 紫杉醇;顺铂;晚期乳腺癌;蒽环类 [gap=920]KEY WORDS] Paclitaxel;Cisplatin; Advanced breast cancer; Anthracycines
基于52个网页-相关网页
蒽环类药物 anthracycline ; Anthracene nucleus chemotherapeutics
蒽环类抗生素 Anthracycline antibiotics ; anthracycline
蒽环类抗癌药物 anthracycline anticancer drug
蒽环类药物/耐药 anthracycline/resistant
蒽环类抗生素米托蒽醌 mitoxantrone
加蒽环类 ADM or EPI
蒽环类化合物 anthracycline
蒽环类抗肿瘤药 Anthracycline
蒽环糖苷类抗生素 anthracycline glycoside antibiotics
·2,447,543篇论文数据，部分数据来源于NoteExpress
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
目的观察吉西他滨联合卡培他滨治疗蒽环类耐药性晚期乳腺癌的疗效与毒性反应。
Objective To observe the results of gemcitabine combined with capecitabine on anthracycline-resistant breast cancer.
对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P<0。01）。
Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P <0.01).
应用推荐